Recent quotes:

“What we’re hearing is that 80% of the biotechs in the United States today, public and private, have less than a year’s worth of cash. That’s going to force massive consolidation.” - James A. Datin, VP and managing director, Safeguard Scientifics (http://www.pharmalive.com/extra/2009/jan09_biotechnology.cfm)

“Nearly one third of the small biotech pharma companies in the US are expected to go out of business within a year.” - Roger S Newton, CEO Esperion Therapeutics (http://economictimes.indiatimes.com/News/News_By_Industry/One_third_of_small_biotech_pharma_cos_in_US_to_loose_biz/articleshow/4071531.cms)